Medical doctors, Pharmacist, EDC, Medical Lab Technologists, study coordinator and Nurses are urgently required in "A Phase 3 Randomized, Double- Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients with COVID-19" at Registrar Office, SOD, Shaheed Zulfiqar Ali Bhutto Medical University, PIMS, G-8/3, Islamabad. This trial is funded by Atea Pharmaceuticals. Working timings will be 9 am to 5 pm, six days a week. Medical doctors, and Nurses must have registered with PM&DC/PNC.

Walk-in interviews will be conducted on 10:00 a.m., 7th August, 2023 at Registrar Office, 5th Floor School of Dentistry, Shaheed Zulfiqar Ali Bhutto Medical University, Ravi Road, G-8/3, Islamabad.